Main Address
5625 Eiger Road, Ste. 200; Austin, TX 78735

ACO Primary Contacts
Dr. Kevin Spencer, President
kspencer@swproviderpartners.com
512-814-1800

Composition of ACO
SW Provider Partners LLC is a Texas, Limited Liability Company comprised of networks of individual practices of ACO professionals.

ACO Participants
South Austin Family Practice Clinic, LLP; (dba Premier Family Physicians)
Mark C Dawson,MD N
Daniel Rasor, MD, PA N
Lifshen Family Clinic, PA N
Ralph S. Sharman, Jr, MD, PA N
Sadhana S. Patel, MD, PA Family P N
Family Health Center of Bastrop, PLC
Laurier A. Vocal, MD N
Preventiamed, PA
The Austin Diagnostic Clinic Association,PA

*No participants are involved in a joint venture between ACO professionals and hospitals

Contact CMS
For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048.

SW Provider Partners Governing Body
Dr. Kevin Spencer, Voting Member, President, ACO Participant Representative – South Austin Family Practice Clinic, LLP
Dr. Kurt Frederick, Voting Member, Medical Director, ACO Participant Representative – South Austin Family Practice Clinic, LLP
Dr. Pompeyo Chavez, Voting Member, Secretary, ACO Participant Representative – Family Health Center of Bastrop, PLC
Toni Pavlos, Voting Member, Medicare Beneficiary
Rich Steinle, Non-Voting Member, Other
David McCormick, Non-Voting Member, Other
Dr. Mark Dawson, Voting Member, Chief Quality Officer, ACO Participant Representative – – South Austin Family Practice Clinic, LLP
Dr. Dieter Martin, Voting Member, ACO Participant Representative – Preventiamed, PA

SW Provider Partners Committees and Key Leadership Personnel
Clinical Initiatives Committee, Dr. Kurt Frederick (Chair)
Financing and Contracting Committee, Dr. Kevin Spencer (Chair)
Information Technology Committee, Dr. Mark Dawson (Chair)

organ again

Amount of Shared Savings/Losses
Performance Year 1: Not in Operation
Performance Year 2014: $0

Identification of the Types of ACO Participants or Combinations of Participants that Formed the ACO:
SW Provider Partners, LLC is a Texas, Limited Liability Company comprised of networks of individual practices of ACO professionals.

How Shared Savings Are Distributed
Reinvestment in the ACO Infrastructure – 75%
Includes rewarding ACO providers and suppliers, as well as development of complex case management, care coordination, analytics, redesigning care processes, and physician education.
Rewarding Quality and Cost-efficient Care of the ACO Participants – 25%
Used to reward physician quality outcomes, beneficiary satisfaction, and financial efficiency in the coordination of care.

Quality Performance Results
Measure Number, Performance Measure, ACO Performance Rate, Mean Performance Rate for all ACOs

Measure Number Measure Name 2015 ACO Performance Rate 2015 Mean Performance Rate (SSP – ACO)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information  80.61 80.61
ACO-2 ACO-2 CAHPS: How Well Your Providers Communicate  92.88 92.65
ACO-3 CAHPS: Patients’ Rating of Provider  92.45  91.94
ACO-4 CAHPS: Access to Specialists  85.50  83.61
ACO-5 CAHPS: Health Promotion and Education  54.72  59.06
ACO-6 CAHPS: Shared Decision Making  69.28  75.17
ACO-7 CAHPS: Health Status/Functional Status  70.61  72.30
ACO-34 CAHPS: Stewardship of Patient Resources*  27.79  26.87
ACO-8 Risk Standardized, All Condition Readmission  15.44  14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission  19.60  18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes*  56.77 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure*  75.19 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions  65.35 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)  .97 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)  .83 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements  86.67%  80.14%
ACO-39 Documentation of Current Medications in the Medical Record*  91.07%  84.07%
ACO-13 Falls: Screening for Future Fall Risk  49.29%  56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization  62.9%  62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults  71.63%  63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up  60.51%  71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention  91.32%  90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan  55.08%  45.25%
ACO-19 Colorectal Cancer Screening  58.76%  60.06%
ACO-20 Breast Cancer Screening  65.99%  65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented  76.9%  70.04%
ACO-40 Depression Remission at Twelve Months*  ———  6.11%
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control  39.88% 20.38%
ACO-41 Diabetes: Eye Exam*  39.31% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure  59.36% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic  78.98%  83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)  83.33%  87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)  70.83%  77.73%

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease. *= Measure required beginning Reporting Year 2015. N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

 

Measure number Performance Measure 2012 ACO
Performance Rate
2012 Mean Performance
Rate for all ACOs
2013 ACO
Performance Rate
2013 Mean
Performance
Rate for all ACOs
2014 ACO
Performance Rate
2014 Mean
Performance
Rate for all ACOs
ACO #1 Getting Timely Care, Appointments and Information Not in Operation Not in Operation Not in Operation Not in Operation 83.37 80.13
ACO #2 How Well Your Doctors Communicate Not in Operation Not in Operation Not in Operation Not in Operation 92.44 92.39
ACO #3 Patients’ Rating of Doctor Not in Operation Not in Operation Not in Operation Not in Operation 91.57 91.58
ACO #4 Access to Specialists Not in Operation Not in Operation Not in Operation Not in Operation 87.42 83.97
ACO #5 Health Promotion and Education Not in Operation Not in Operation Not in Operation Not in Operation 63.1 58.29
ACO #6 Shared Decision Making Not in Operation Not in Operation Not in Operation Not in Operation 78.15 74.6
ACO #7 Health Status/Functional Status Not in Operation Not in Operation Not in Operation Not in Operation 70.29 71.1
ACO #8 Risk Standardized, All Condition Readmissions Not in Operation Not in Operation Not in Operation Not in Operation 14.48 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults Not in Operation Not in Operation Not in Operation Not in Operation 1.42 1.08
ACO #10 ASC Admission: Heart Failure Not in Operation Not in Operation Not in Operation Not in Operation 1.13 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment Not in Operation Not in Operation Not in Operation Not in Operation 92.16 76.71
ACO #12 Medication Reconciliation Not in Operation Not in Operation Not in Operation Not in Operation 78.82 82.61
ACO #13 Falls: Screening for Fall Risk Not in Operation Not in Operation Not in Operation Not in Operation 45.22 45.6
ACO #14 Influenza Immunization Not in Operation Not in Operation Not in Operation Not in Operation 60.56 57.51
ACO #15 Pneumococcal Vaccination Not in Operation Not in Operation Not in Operation Not in Operation 73.5 55.03
ACO #16 Adult Weight Screening and Follow-up Not in Operation Not in Operation Not in Operation Not in Operation 66.49 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention Not in Operation Not in Operation Not in Operation Not in Operation 92.48 86.79
ACO #18 Depression Screening Not in Operation Not in Operation Not in Operation Not in Operation 51.07 39.27
ACO #19 Colorectal Cancer Screening Not in Operation Not in Operation Not in Operation Not in Operation 63.93 56.14
ACO #20 Mammography Screening Not in Operation Not in Operation Not in Operation Not in Operation 71.52 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years Not in Operation Not in Operation Not in Operation Not in Operation 55.07 60.24
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) ACO #24 Blood Pressure (BP) <140/90 Not in Operation Not in Operation Not in Operation Not in Operation 72.05 N/A
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) Not in Operation Not in Operation Not in Operation Not in Operation N/A N/A
ACO #24 Blood Pressure (BP) <140/90 Not in Operation Not in Operation Not in Operation Not in Operation 69.32 N/A
ACO #25 Tobacco Non Use Not in Operation Not in Operation Not in Operation Not in Operation 86.59 N/A
ACO #26 Aspirin Use Not in Operation Not in Operation Not in Operation Not in Operation 76.82 N/A
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) Not in Operation Not in Operation Not in Operation Not in Operation 17.16 20.35
ACO #28 Percent of beneficiaries with hypertension whose BP <140/90 Not in Operation Not in Operation Not in Operation Not in Operation 69.07 68.02
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl Not in Operation Not in Operation Not in Operation Not in Operation N/A N/A
ACO #30 Percent of beneficiaries with IVD who use Aspirin or other antithrombotic Not in Operation Not in Operation Not in Operation Not in Operation 86.42 80.79
ACO #31 Beta-Blocker Therapy for LVSD Not in Operation Not in Operation Not in Operation Not in Operation 87.7 82.72
ACO #32 Drug Therapy for Lowering LDL Cholesterol Not in Operation Not in Operation Not in Operation Not in Operation N/A N/A
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD Not in Operation Not in Operation Not in Operation Not in Operation 64.78 N/A